Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

9amHealth vs PauseRX

9amHealth
Graded #93

Higher grade

vs+2.799999999999997
PauseRX
Graded #147

Lower grade

The verdict

9amHealth takes it — 71.3/100 to 68.5/100.

9amHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. 9amHealth (join9am.com) is a cardiometabolic telehealth platform offering whole-body care including weight management with FDA-approved branded GLP-1 medications such as Wegovy, Zepbound, and Saxenda, plus…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost value9amHealth +2
68
66
Dose & formulationPauseRX +20
65
85
Clinical oversight9amHealth +5
88
83
Labs & monitoring9amHealth +22
74
52
Fulfillment9amHealth +7
68
61
Contract terms9amHealth +14
55
41
9amHealth · left barPauseRX · right bar

The numbers

Metric9amHealthPauseRX
WeighScore71.3/10068.5/100
GradeCC
Scorecard rank#93#147
Semaglutide$149/mo (plus a separate fee, brand-name)$199/mo
TirzepatideNot disclosed$249/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
9amHealth

Graded #93 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound, Saxenda)
  • $149/month membership or free when covered by insurance
  • Membership includes specialists, labs, devices, and medications
  • Board-certified obesity specialists (DABOM), endocrinologists, dietitians, PharmDs
  • Helps navigate insurance approvals; employer and state-plan partnerships

Where it loses points

  • Medication coverage and GLP-1 access depend on insurance and BMI criteria
  • State availability not enumerated on the public site
  • Branded GLP-1s can be costly without insurance coverage
  • Pricing for medications not transparently listed
PauseRX

Graded #147 · C

Strengths

  • Names its 503A pharmacy partner (Strive Pharmacy, Gilbert AZ) — buyers can independently verify its licensure
  • Names its physician network (Beluga Health) — you can research the clinical platform handling your prescriptions
  • Publishes the FDA compounded-medication disclaimer
  • Corporate legal entity disclosed (PauseRX, Inc.) — uncommon for direct-to-consumer GLP-1 platforms
  • Flat $199 'all doses' compounded semaglutide pricing — no per-tier escalation

Where it loses points

  • States served not listed — site claims nationwide, but you must contact support to confirm availability
  • Restrictive cancellation policy — orders can't be changed or canceled once submitted, and medications can't be returned
  • No named medical director (Beluga Health is the network, not a named MD)
  • LegitScript certification number not shown — badge only, so no direct lookup
  • Insurance not accepted — cash-pay only; HSA/FSA eligibility not confirmed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard